Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.36 Insider Own29.36% Shs Outstand24.44M Perf Week4.23%
Market Cap48.32M Forward P/E- EPS next Y-2.67 Insider Trans-3.38% Shs Float17.33M Perf Month10.67%
Income-63.41M PEG- EPS next Q-0.65 Inst Own41.67% Short Float5.71% Perf Quarter-63.59%
Sales23.25M P/S2.08 EPS this Y7.36% Inst Trans13.63% Short Ratio2.17 Perf Half Y-70.64%
Book/sh4.82 P/B0.41 EPS next Y-7.24% ROA-38.00% Short Interest0.99M Perf Year-81.71%
Cash/sh4.86 P/C0.40 EPS next 5Y- ROE-44.14% 52W Range1.55 - 11.00 Perf YTD-2.48%
Dividend Est.- P/FCF- EPS past 5Y29.51% ROI-53.22% 52W High-82.09% Beta0.58
Dividend TTM- Quick Ratio6.30 Sales past 5Y266.56% Gross Margin91.50% 52W Low27.10% ATR (14)0.11
Dividend Ex-Date- Current Ratio6.48 EPS Y/Y TTM20.84% Oper. Margin-299.67% RSI (14)51.29 Volatility5.49% 5.28%
Employees79 Debt/Eq0.06 Sales Y/Y TTM111.62% Profit Margin-272.66% Recom1.40 Target Price17.75
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q11.09% Payout- Rel Volume0.60 Prev Close2.07
Sales Surprise-9.98% EPS Surprise17.13% Sales Q/Q40.38% EarningsNov 08 BMO Avg Volume455.69K Price1.97
SMA205.72% SMA505.57% SMA200-59.23% Trades Volume273,510 Change-4.83%
Date Action Analyst Rating Change Price Target Change
Dec-15-23Downgrade H.C. Wainwright Buy → Neutral
Jan-11-22Initiated Jefferies Buy $45
Oct-01-21Initiated Cowen Outperform
Sep-14-21Initiated Ladenburg Thalmann Buy $51
Sep-08-21Initiated Piper Sandler Overweight $45
Feb-26-24 04:05PM
Jan-26-24 04:05PM
Jan-19-24 04:05PM
Dec-15-23 09:14AM
Dec-14-23 04:05PM
08:46AM Loading…
Nov-08-23 08:46AM
Nov-06-23 04:05PM
Nov-01-23 04:05PM
Oct-19-23 04:05PM
Oct-12-23 04:05PM
Oct-05-23 04:05PM
Oct-03-23 04:05PM
Oct-02-23 08:00AM
Sep-20-23 04:30PM
08:00AM Loading…
Sep-05-23 08:00AM
Aug-09-23 08:00AM
Aug-02-23 08:00AM
May-25-23 05:30PM
May-23-23 08:00AM
May-10-23 08:00AM
May-03-23 08:00AM
Apr-26-23 04:05PM
Apr-14-23 01:00PM
Apr-06-23 04:30PM
Mar-28-23 08:00AM
Mar-27-23 08:00AM
Mar-26-23 02:00PM
Mar-15-23 08:00AM
Mar-03-23 08:00AM
08:00AM Loading…
Feb-22-23 08:00AM
Nov-17-22 08:00AM
Nov-09-22 08:00AM
Nov-08-22 04:00PM
Nov-03-22 08:00AM
Oct-27-22 08:00AM
Oct-12-22 08:01AM
Sep-22-22 04:01PM
Sep-01-22 08:00AM
Aug-10-22 08:00AM
Aug-04-22 06:21AM
Jul-28-22 08:30AM
Jun-23-22 08:00AM
Jun-01-22 08:00AM
May-31-22 08:00AM
May-26-22 05:10PM
May-18-22 07:00AM
May-12-22 08:32AM
May-09-22 08:00AM
May-04-22 08:00AM
Apr-28-22 05:07PM
Apr-18-22 08:00AM
Apr-08-22 01:09PM
Apr-01-22 05:13AM
Mar-31-22 02:45PM
Mar-17-22 07:00AM
Mar-01-22 07:00AM
Feb-25-22 04:41AM
Feb-23-22 07:00AM
Jan-04-22 04:30PM
Dec-28-21 09:38AM
Dec-23-21 12:38PM
Dec-21-21 09:38AM
Dec-16-21 09:38AM
Dec-08-21 09:38AM
Nov-27-21 06:01AM
Nov-23-21 04:22PM
Nov-15-21 08:00AM
Nov-13-21 01:35PM
Nov-10-21 07:00AM
Nov-09-21 08:00AM
Nov-01-21 04:05PM
Oct-25-21 08:00AM
Oct-22-21 08:00AM
Oct-19-21 05:22PM
Oct-06-21 08:00AM
Sep-20-21 08:30AM
Sep-13-21 08:00AM
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai on November 2007 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Desai NeilExecutive ChairmanFeb 01Sale1.7442,00073,2691,453,543Feb 02 05:04 PM
Desai NeilExecutive ChairmanJan 02Sale2.0642,00086,5491,495,543Jan 02 07:48 PM
Desai NeilExecutive ChairmanDec 06Sale4.827,03733,9141,537,543Dec 07 04:04 PM
Desai NeilExecutive ChairmanDec 05Sale5.0215,74078,9411,544,580Dec 05 06:40 PM
Desai NeilExecutive ChairmanDec 04Sale5.1510,87655,9861,560,320Dec 05 06:40 PM
Desai NeilExecutive ChairmanDec 01Sale5.148,34742,8811,571,196Dec 05 06:40 PM
Desai NeilExecutive ChairmanNov 02Sale4.4631,662141,1051,579,543Nov 02 06:45 PM
Desai NeilExecutive ChairmanNov 01Sale4.3210,33844,6451,611,205Nov 02 06:45 PM
Desai NeilExecutive ChairmanOct 03Sale4.1016,43167,3031,621,543Oct 03 06:51 PM
Desai NeilExecutive ChairmanOct 02Sale4.3725,569111,6981,637,974Oct 03 06:51 PM
Desai NeilExecutive ChairmanSep 06Sale5.297,11137,6371,663,543Sep 06 07:05 PM
Desai NeilExecutive ChairmanSep 05Sale5.6321,000118,3161,670,654Sep 06 07:05 PM
Desai NeilExecutive ChairmanSep 01Sale5.9713,88982,8731,691,654Sep 06 07:05 PM
Desai NeilExecutive ChairmanAug 02Sale5.2019,290100,2501,705,543Aug 03 04:22 PM
Desai NeilExecutive ChairmanAug 01Sale5.2222,710118,5231,724,833Aug 03 04:22 PM
Desai NeilExecutive ChairmanJul 06Sale6.2715,82999,2731,747,543Jul 06 07:36 PM
Desai NeilExecutive ChairmanJul 05Sale6.5516,171105,8731,763,372Jul 06 07:36 PM
Desai NeilExecutive ChairmanJul 03Sale6.6410,00066,4461,779,543Jul 06 07:36 PM
Desai NeilExecutive ChairmanJun 06Sale8.197,26059,4531,789,543Jun 06 08:11 PM
Desai NeilExecutive ChairmanJun 05Sale8.1117,315140,4181,796,803Jun 05 07:01 PM
Desai NeilExecutive ChairmanJun 02Sale7.9912,44399,4211,814,118Jun 05 07:01 PM
Desai NeilExecutive ChairmanJun 01Sale7.924,98239,4681,826,561Jun 05 07:01 PM
Desai NeilExecutive ChairmanMay 04Sale7.572,30517,4451,831,543May 05 04:16 PM
Desai NeilExecutive ChairmanMay 03Sale7.687,69559,0731,833,848May 03 06:55 PM
Desai NeilExecutive ChairmanMay 02Sale7.487,52156,2251,841,543May 03 06:55 PM
Desai NeilExecutive ChairmanMay 01Sale7.8024,479190,8951,849,064May 03 06:55 PM
Desai NeilExecutive ChairmanApr 06Sale7.0912,21286,6161,873,543Apr 06 08:45 PM
Desai NeilExecutive ChairmanApr 05Sale7.247,33653,0761,885,755Apr 05 07:32 PM
Desai NeilExecutive ChairmanApr 04Sale7.3012,86993,9811,893,091Apr 05 07:32 PM
Desai NeilExecutive ChairmanApr 03Sale7.459,58371,3551,905,960Apr 05 07:32 PM